New Page 1
The Holy Grail
Patients across the world are holding on to the tenuous thread of life by
the hope stem cell therapy provides while the research itself is facing
challenges of all kinds-scientific, political, legal and ethical. In this
special report BioSpectrum captures what the business leaders are doing to
commercialize the research and sustain until we reach the goalpost.
Penetration of Stem Cell Therapy in APAC Region
Singapore has the highest penetration for stem cell
therapy, achieving almost 25% penetration rate by 2010.
Both Thailand & Taiwan have similar penetration
rates achieving overall penetration of almost 4% by 2010.
Malaysia on the other hand has a relatively lower
penetration rate at 1.2% by 2010.
India offers penetration of 5% by 2010 largely
accounted by stem cell therapies derived out of cord blood banking. It
three international players already creating a headstart.
- In the APAC regions, Singapore has the highest penetration with a
CAGR of almost 66% for market penetration over the next five years.
Malaysia leads second with a CAGR of 33%. Taiwan & Thailand lead
on the basis of sheer numbers, but would have a comparatively lower
demand trajectory due to restrictive healthcare policies. Source:
Narayan Kulkarni & Sanjeev Jain